MSK
Morgan Stanley Capital Trust VIII
DELISTED - Morgan Stanley Capital Trust VIII (the Trust) is a trust that exists solely to issue and sell its common securities to Morgan Stanley, and issues and sells its capital securities to the public. The Trust uses the proceeds from the sale of its common securities and capital securities to purchase junior subordinated debentures from Morgan Stanley, and engages in other activities that are necessary or incidental to these purposes. The Trust holds directly or indirectly all of the common securities of each of the Morgan Stanley Capital Trusts. The junior subordinated debentures will be the Trust's only assets.
Current Price
$25.76
GoodMoat Value
$6.65
74.2% overvaluedMorgan Stanley Capital Trust VIII (MSK) Quality Analysis
MSK Profitability
MSK Growth
MSK Financial Health
MSK Quality & Fundamental Analysis
Morgan Stanley Capital Trust VIII (MSK) is a Consumer Defensive company in the Packaged Foods industry, listed on NYSE. This quality analysis page evaluates Morgan Stanley Capital Trust VIII's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Morgan Stanley Capital Trust VIII has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 7.01% and a return on equity (ROE) of 7.06%. Return on assets (ROA) stands at 5.44%.
with a current ratio of 7.24. Operating margin is 7.79%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Morgan Stanley Capital Trust VIII is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.